Literature DB >> 28526709

Acetylation of mitochondrial proteins by GCN5L1 promotes enhanced fatty acid oxidation in the heart.

Dharendra Thapa1,2,3, Manling Zhang1,2,3, Janet R Manning1,2,3, Danielle A Guimarães4,2,3, Michael W Stoner1,2,3, Robert M O'Doherty5,3, Sruti Shiva4,2,3, Iain Scott6,2,3.   

Abstract

Lysine acetylation is a reversible posttranslational modification and is particularly important in the regulation of mitochondrial metabolic enzymes. Acetylation uses acetyl-CoA derived from fuel metabolism as a cofactor, thereby linking nutrition to metabolic activity. In the present study, we investigated how mitochondrial acetylation status in the heart is controlled by food intake and how these changes affect mitochondrial metabolism. We found that there was a significant increase in cardiac mitochondrial protein acetylation in mice fed a long-term high-fat diet and that this change correlated with an increase in the abundance of the mitochondrial acetyltransferase-related protein GCN5L1. We showed that the acetylation status of several mitochondrial fatty acid oxidation enzymes (long-chain acyl-CoA dehydrogenase, short-chain acyl-CoA dehydrogenase, and hydroxyacyl-CoA dehydrogenase) and a pyruvate oxidation enzyme (pyruvate dehydrogenase) was significantly upregulated in high-fat diet-fed mice and that the increase in long-chain and short-chain acyl-CoA dehydrogenase acetylation correlated with increased enzymatic activity. Finally, we demonstrated that the acetylation of mitochondrial fatty acid oxidation proteins was decreased after GCN5L1 knockdown and that the reduced acetylation led to diminished fatty acid oxidation in cultured H9C2 cells. These data indicate that lysine acetylation promotes fatty acid oxidation in the heart and that this modification is regulated in part by the activity of GCN5L1.NEW & NOTEWORTHY Recent research has shown that acetylation of mitochondrial fatty acid oxidation enzymes has greatly contrasting effects on their activity in different tissues. Here, we provide new evidence that acetylation of cardiac mitochondrial fatty acid oxidation enzymes by GCN5L1 significantly upregulates their activity in diet-induced obese mice.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  GCN5L1; acetylation; fatty acid oxidation; heart; high-fat diet; mitochondria; sirtuin 3

Mesh:

Substances:

Year:  2017        PMID: 28526709      PMCID: PMC5582919          DOI: 10.1152/ajpheart.00752.2016

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  41 in total

1.  Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism.

Authors:  R J BING; A SIEGEL; I UNGAR; M GILBERT
Journal:  Am J Med       Date:  1954-04       Impact factor: 4.965

2.  Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1.

Authors:  Iain Scott; Bradley R Webster; Jian H Li; Michael N Sack
Journal:  Biochem J       Date:  2012-05-01       Impact factor: 3.857

Review 3.  The failing heart--an engine out of fuel.

Authors:  Stefan Neubauer
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

Review 4.  Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle.

Authors:  J R Neely; H E Morgan
Journal:  Annu Rev Physiol       Date:  1974       Impact factor: 19.318

Review 5.  Myocardial utilization of carbohydrate and lipids.

Authors:  J R Neely; M J Rovetto; J F Oram
Journal:  Prog Cardiovasc Dis       Date:  1972 Nov-Dec       Impact factor: 8.194

Review 6.  Mitochondria in metabolic disease: getting clues from proteomic studies.

Authors:  Juan R Peinado; Alberto Diaz-Ruiz; Gema Frühbeck; Maria M Malagon
Journal:  Proteomics       Date:  2014-03       Impact factor: 3.984

7.  Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux.

Authors:  Qijun Wang; Yakun Zhang; Chen Yang; Hui Xiong; Yan Lin; Jun Yao; Hong Li; Lu Xie; Wei Zhao; Yufeng Yao; Zhi-Bin Ning; Rong Zeng; Yue Xiong; Kun-Liang Guan; Shimin Zhao; Guo-Ping Zhao
Journal:  Science       Date:  2010-02-19       Impact factor: 47.728

8.  Regulation of cellular metabolism by protein lysine acetylation.

Authors:  Shimin Zhao; Wei Xu; Wenqing Jiang; Wei Yu; Yan Lin; Tengfei Zhang; Jun Yao; Li Zhou; Yaxue Zeng; Hong Li; Yixue Li; Jiong Shi; Wenlin An; Susan M Hancock; Fuchu He; Lunxiu Qin; Jason Chin; Pengyuan Yang; Xian Chen; Qunying Lei; Yue Xiong; Kun-Liang Guan
Journal:  Science       Date:  2010-02-19       Impact factor: 47.728

Review 9.  Mitochondrial metabolism, sirtuins, and aging.

Authors:  Michael N Sack; Toren Finkel
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

10.  The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase.

Authors:  Bjorn Schwer; Brian J North; Roy A Frye; Melanie Ott; Eric Verdin
Journal:  J Cell Biol       Date:  2002-08-19       Impact factor: 10.539

View more
  23 in total

1.  Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt/mTORC2 signaling.

Authors:  Janet R Manning; Dharendra Thapa; Manling Zhang; Michael W Stoner; Javier Traba; Catherine Corey; Sruti Shiva; Michael N Sack; Iain Scott
Journal:  Biochem J       Date:  2019-06-19       Impact factor: 3.857

2.  Statistical considerations in reporting cardiovascular research.

Authors:  Merry L Lindsey; Gillian A Gray; Susan K Wood; Douglas Curran-Everett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

3.  Cardiac-specific deletion of GCN5L1 restricts recovery from ischemia-reperfusion injury.

Authors:  Janet R Manning; Dharendra Thapa; Manling Zhang; Michael W Stoner; Javier Traba; Charles F McTiernan; Catherine Corey; Sruti Shiva; Michael N Sack; Iain Scott
Journal:  J Mol Cell Cardiol       Date:  2019-02-15       Impact factor: 5.000

4.  Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.

Authors:  Kim L Ho; Liyan Zhang; Cory Wagg; Rami Al Batran; Keshav Gopal; Jody Levasseur; Teresa Leone; Jason R B Dyck; John R Ussher; Deborah M Muoio; Daniel P Kelly; Gary D Lopaschuk
Journal:  Cardiovasc Res       Date:  2019-09-01       Impact factor: 10.787

5.  Adropin treatment restores cardiac glucose oxidation in pre-diabetic obese mice.

Authors:  Dharendra Thapa; Bingxian Xie; Manling Zhang; Michael W Stoner; Janet R Manning; Brydie R Huckestein; Lia R Edmunds; Steven J Mullett; Charles F McTiernan; Stacy G Wendell; Michael J Jurczak; Iain Scott
Journal:  J Mol Cell Cardiol       Date:  2019-02-26       Impact factor: 5.000

Review 6.  Mitochondrial dysfunction in pathophysiology of heart failure.

Authors:  Bo Zhou; Rong Tian
Journal:  J Clin Invest       Date:  2018-08-20       Impact factor: 14.808

Review 7.  A "Weird" Mitochondrial Fatty Acid Oxidation as a Metabolic "Secret" of Cancer.

Authors:  Zhivko Zhelev; Ichio Aoki; Dessislava Lazarova; Tatyana Vlaykova; Tatsuya Higashi; Rumiana Bakalova
Journal:  Oxid Med Cell Longev       Date:  2022-02-08       Impact factor: 6.543

8.  GPER-dependent estrogen signaling increases cardiac GCN5L1 expression.

Authors:  Janet R Manning; Dharendra Thapa; Manling Zhang; Michael W Stoner; John C Sembrat; Mauricio Rojas; Iain Scott
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-04       Impact factor: 4.733

9.  GCN5L1 interacts with αTAT1 and RanBP2 to regulate hepatic α-tubulin acetylation and lysosome trafficking.

Authors:  Kaiyuan Wu; Lingdi Wang; Yong Chen; Mehdi Pirooznia; Komudi Singh; Sarah Wälde; Ralph H Kehlenbach; Iain Scott; Marjan Gucek; Michael N Sack
Journal:  J Cell Sci       Date:  2018-11-20       Impact factor: 5.285

Review 10.  GCN5L1/BLOS1 Links Acetylation, Organelle Remodeling, and Metabolism.

Authors:  Iain Scott; Lingdi Wang; Kaiyuan Wu; Dharendra Thapa; Michael N Sack
Journal:  Trends Cell Biol       Date:  2018-02-21       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.